Are you Ready? ArcheMedX platform serves as an early warning detection, says CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/ComicSans)
(Image: Getty/ComicSans)

Related tags: ArcheMedX, Clinical trial sites, Risk

ArcheMedX’s new digital platform aims to reduce the risks and costs associated with underperforming clinical trials by analyzing the behavior of project teams and site personnel.

ArcheMedX, a provider of operational intelligence and workforce readiness solutions, launched the new digital platform, Ready, at this year’s DIA Global Annual Meeting.

According to the company, Ready is currently being used by contract research organizations (CROs), sponsors, and other clinical trial stakeholders.

The platform is used to evaluate “the readiness of project teams and site personnel, detect which staff or sites are most likely to struggle, and focus critical resources to improve preparedness and reduce the risks and costs associated with underperforming sites,”​ said Joel Selzer, ArcheMedX co-founder and CEO.

Selzer described Ready as a platform “that enables clinical operations leaders to evaluate and improve the preparedness of project teams and site personnel.”

“The specific and actionable insights delivered by the platform serve as an early warning detection system to identify risks sooner, ensure resources are more effectively deployed, and enhance staff and site performance,”​ he told us.

Selzer explained that Ready analyzes project teams and site personnel behavior “as they engage in personalized learning experiences.”

“The rich behavioral data generated as they engage in the platform enables Ready to assess their individual mindset and readiness across potential areas of risk,” ​he said, explaining that the platform correlates and visualizes this data against benchmarks to provide insights and recommendations.

Related news

Related products

show more

The Essential Clinical Development Resource Center

The Essential Clinical Development Resource Center

Data Management Solution Center | 05-Mar-2020 | Data Sheet

Clinical trials are becoming increasingly complex with oversight workloads increasing too. A recent survey based study conducted by Medidata in association...

Infographic:Transforming Data Capture & Management

Infographic:Transforming Data Capture & Management

Data Management Solution Center | 05-Mar-2020 | Infographic

Is your clinical study's data capture and management processes efficient? Medidata Rave Clinical Cloud is the only industry platform that creates...

Electronic Informed Consent and Global Regulation

Electronic Informed Consent and Global Regulation

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Medidata is conducting an on-going study to understand global regulatory positions, adoption and variability regarding eConsent. The benefits of eConsent...

De-risk Go/No Go Product Development Decisions

De-risk Go/No Go Product Development Decisions

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist...

Related suppliers

Follow us

Products

View more

Webinars